Unforced Errors and the Need for Discipline
Send in the Troops, Mr. President
Throw the Book at Corrupt Democrats in Minnesota and Everywhere Else
Bishop Barron's Bully Pulpit
It’s Not 'Racism' or 'White Supremacy,' It’s the Declaration of Independence
A Bad Bet
This Is No Way to Gimme Shelter
America's Three-Party System
The Neighborhoods the Silent Generation Built
AI and Gambling: The Two Fastest-Growing Sectors of the Economy
John Marshall: Judicial Independence and the Safeguard of Religious Liberty
While Canada Moves Against the U.S. Over Greenland, We Just Beat Them at...
The Crowd Went Crazy After Seeing Trump at the College Football National Championship
DOJ to Investigate and Arrest Don Lemon and Minneapolis Church Stormers
DHS Just Announced Huge Arrest Numbers in Minnesota
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos